1,4-Butane sultone:Exports & Compliance White Paper 2026

I. Executive Summary

1,4-Butane sultone, abbreviated BS and identified by CAS 1633-83-6, is a six-membered cyclic sulfonate ester of formula C4H8O3S with a molar mass of 136.17 g/mol. It is a strong alkylating agent that transfers a sulfobutyl group to nucleophiles, opening the ring to give a tethered sulfonate. That single reaction underpins two very different markets: the substance is a film-forming electrolyte additive in lithium-ion cells, where small loadings improve high-temperature behaviour and cycle life, and it is the key sulfobutylating reagent used to make sulfobutyl ether cyclodextrins and other sulfonated intermediates.

Compliance, not chemistry, is the binding constraint on this trade. Sultones are electrophilic alkylators, and buyers must verify the carcinogenicity and mutagenicity classification applicable to this substance against the current harmonised classification and labelling inventory and the latest adaptation to technical progress rather than relying on inherited safety data sheets; the better-known 1,3-propane sultone carries a harmonised carcinogen classification in the European Union, and the class is treated conservatively by regulators and hygienists. Practical consequences include occupational exposure banding, closed-system handling, health surveillance, and mutagenic impurity control under ICH M7 wherever residues touch pharmaceutical manufacture.

Commercially, the product is bifurcated by purity architecture. Battery grade competes on water, free acid, chloride, and trace metals, because those species degrade cell performance and corrode current collectors; reagent and pharmaceutical grade competes on documented impurity profiles, genotoxic impurity assessment, and containment-backed manufacturing. This paper sets out the specification architecture, the occupational and transport controls, the comparison with 1,3-propane sultone, and the substitution trends that sourcing teams must price into multi-year contracts.

II. Product Deep Dive: Molecular Mechanisms and Production Evolution

2.1 Physicochemical Properties and Mechanisms

The reactivity of BS follows from ring strain and from the excellent leaving group character of the sulfonate. Nucleophilic attack at carbon opens the strained cyclic ester to give a 4-sulfobutyl derivative, so a single operation installs a flexible four-carbon spacer terminated by a permanently ionised sulfonate. This is why the molecule is so effective at converting neutral or cationic substrates into anionic, water-compatible derivatives, and why it is simultaneously hazardous: the same electrophilic attack occurs at nucleophilic sites in DNA, which is the toxicological basis for conservative classification and handling.

• Sulfobutylation mechanism and selectivity: Under basic conditions an alkoxide, amine, or thiolate attacks the methylene adjacent to oxygen, opening the ring regiospecifically to give a sulfobutyl ether, amine, or thioether. Because the reaction is quantitative and introduces no leaving-group salt other than the sulfonate already in the product, it is favoured for pharmaceutical derivatisation where stoichiometric cleanliness and controlled substitution degree matter.
• Electrolyte film formation in lithium-ion cells: At the negative electrode the sultone is reduced preferentially to the carbonate solvent and its ring-opening products participate in forming a stable, ion-conducting solid electrolyte interphase, while at the positive electrode it contributes to a protective cathode film. The practical outcome is suppressed gas generation, reduced transition metal dissolution, and improved capacity retention at elevated temperature and high voltage.

2.2 Synthesis and Manufacturing Technologies

Industrial routes converge on a hydroxy sulfonic acid intermediate that is cyclised by intramolecular dehydration, with the chemistry kept at a route-class level here because the operational differentiator is containment and purification rather than the bond-forming step. Producers able to run high-vacuum fractional distillation or melt crystallisation with tight thermal control, and to finish and sample the product in closed systems, are the ones able to supply electronic and pharmaceutical grades consistently.

• Hydroxysulfonate formation and cyclodehydration: A haloalkanol or alkenol precursor is converted to the corresponding 4-hydroxybutanesulfonate, then acidified and cyclised under reduced pressure with continuous water removal to drive the equilibrium toward the sultone. Temperature control is critical, because sultones polymerise and darken when overheated, and residual acid and halide carry through into the finished lot unless the intermediate is rigorously purified.
• High-vacuum finishing and closed-system handling: Final purification is by short-path high-vacuum distillation or by melt crystallisation, followed by filtration and filling under dry inert gas in contained equipment with local exhaust and dedicated personal protective equipment. Battery grade additionally requires polishing steps and materials of construction chosen to limit metallic extractables, since iron, sodium, and calcium at part-per-million levels measurably affect cell performance.

2.3 Core Application Matrix

• Lithium-ion battery electrolyte additive: The largest volume outlet. BS is dosed at low weight percentages into carbonate-based electrolytes to stabilise the electrode interfaces, improving high-temperature storage, cycle life, and high-voltage tolerance in cells for electric vehicles, stationary storage, and consumer electronics.
• Sulfobutylation reagent for pharmaceutical excipients and intermediates: The reagent of choice for installing sulfobutyl groups, most notably in the preparation of sulfobutyl ether cyclodextrins used as solubilising excipients, and for sulfonated dye, surfactant, and electroplating additive intermediates where a covalently bound sulfonate is required.
• Specialty surfactant and surface-treatment intermediates: Ring opening with amines, alcohols, or thiols gives sulfobetaines and sulfonated surfactants with permanent anionic character and good hard-water and pH tolerance, used in speciality cleaning, emulsion polymerisation, and plating additive packages.

III. Global Market Supply-Demand Landscape and Export Trends

3.1 Demand Drivers and Market Shifts

Battery demand dominates and is structurally tied to electric vehicle and stationary storage build-out, with additive intensity rising as cell makers push nickel-rich cathodes, higher voltage windows, and longer warranty lives. Pharmaceutical demand is smaller but stickier, because once a sulfobutylated excipient or intermediate is validated in a filing, the reagent source is effectively fixed by change control.

3.2 Capacity Distribution and Export Flows

Capacity is concentrated where electrolyte production is concentrated. China hosts the largest additive base, clustered in Jiangsu, Shandong, and Zhejiang alongside electrolyte blending and cell manufacturing, and supplies both domestic cell makers and export customers. Japan and Korea supply high-purity electronic grade integrated with domestic cell and materials industries, with rigorous trace-metal and water control. Europe and North America hold smaller, containment-equipped custom synthesis capacity serving pharmaceutical and speciality customers, and increasingly act as qualified second sources for battery makers seeking supply chain resilience.

3.3 Market Bifurcation and Pricing Dynamics

Price is set by purity architecture and by hazard cost. Battery grade is quoted against water, free acid, chloride, and metal limits and is bought in bulk at prices sensitive to cell-maker qualification cycles; pharmaceutical grade is quoted against documented impurity profiles and containment-backed manufacture and carries a large premium for smaller volumes. Underlying both is the cost of compliant operation: contained plant, health surveillance, waste destruction, and hazardous transport add fixed cost that low-cost entrants cannot avoid.

IV. In-depth Analysis of Global Compliance and Regulatory Barriers

This is the most regulation-dense product in the series, and compliance must be treated as the primary commercial variable. The substance is an electrophilic alkylator, so the applicable carcinogenicity and mutagenicity classification must be confirmed against the current harmonised classification and labelling inventory and the latest adaptation to technical progress, not assumed from an inherited safety data sheet. Where a carcinogen or mutagen classification applies, obligations escalate immediately: substitution assessment, closed systems, exposure limits and health surveillance for workers, authorisation or restriction exposure for the value chain, and control of the substance as a potentially mutagenic impurity under ICH M7 in pharmaceutical use.

4.1 European Market: REACH, CLP, and Sector-Specific Directives

• REACH registration and carcinogen or mutagen classification: Confirm registration status, tonnage band, and the current classification before contracting, and check whether the substance appears on the candidate list or is subject to authorisation or restriction. Where a carcinogen or mutagen classification applies, the Carcinogens and Mutagens at Work Directive imposes substitution assessment, closed processing, exposure minimisation, health surveillance, and record keeping, which buyers should evidence in supplier audits rather than assume.
• Occupational exposure banding and containment duties: Alkylating sultones are typically assigned to a high occupational exposure band with a health-based exposure limit derived from a permitted daily exposure or similar point of departure. Practical consequences are isolator or glovebox handling, single-pass ventilation, dedicated respiratory protection, prohibited open weighing, and validated decontamination and quench procedures before any equipment leaves containment.

4.2 North American Market: TSCA, EPA, and FDA Regulations

• TSCA inventory and import certification: Verify the active inventory designation before first import and obtain the supplier certification statement for each entry. Importers should also confirm that any applicable significant new use rule or risk management requirement has been assessed, since alkylating agents attract heightened scrutiny under chemical risk programmes.
• ICH M7 mutagenic impurity control in pharmaceutical use: Where the substance is used as a reagent or where it can persist as a residue, it is assessed as a DNA-reactive impurity with an acceptable intake derived from the threshold of toxicological concern or from compound-specific bacterial mutation data. Manufacturers must demonstrate purge by purge-factor reasoning or by measured data, and must set specification limits accordingly, making reagent purity and residual documentation a regulatory deliverable.

4.3 The Critical Hurdle: Quality Control and Safety Limits

V. Green Trade Barriers and ESG in Manufacturing

Environmental and social governance pressure on this molecule is unusually direct. Investors and customers scrutinise worker protection for a genotoxic alkylator, the completeness of waste destruction, and the integrity of containment, and several battery and pharmaceutical customers now audit these practices on site. Suppliers who treat ESG as a documentation exercise rather than as engineering tend to fail those audits, because the evidence auditors ask for is operational: training records, exposure monitoring, health surveillance, and destruction certificates.

5.1 Carbon Footprint and Circular Economy

Battery customers increasingly cascade carbon and due-diligence requirements down to additives. The European Battery Regulation introduces carbon footprint declarations, performance classes, recycled content rules for key metals, and a digital battery passport, all of which oblige cell makers to collect upstream data from additive suppliers. Producers of BS should therefore be prepared to supply product carbon footprint data aligned with ISO 14067, energy and solvent balances, and bio-attributed content claims where available.

5.2 Sustainable Sourcing and Traceability

Traceability here means hazard transparency as much as origin. Responsible suppliers disclose the classification basis, provide exposure scenarios and recommended occupational exposure banding, confirm the absence of intentionally added substances of very high concern, and operate ISO 9001 and ISO 14001 systems with retained samples and full batch genealogy. Waste handling must be explicit: aqueous alkaline hydrolysis converts the sultone to the corresponding hydroxysulfonate, after which the solution can be sent to licensed treatment, and destruction certificates should be issued for every disposed lot.

VI. Supply Chain Resilience and Export Logistics

Two stability mechanisms govern the physical supply chain. Heat accelerates polymerisation and darkening, and moisture hydrolyses the sultone to the open-chain hydroxysulfonic acid, which raises free acid and destroys battery-grade performance. Every packaging and transit decision therefore aims to keep the product cool and dry, and every regulatory decision aims to keep a potent alkylator contained, which together explain why this product is rarely economical to ship in small lots over long distances.

6.1 Packaging Standards and Moisture/Contamination Control

• Sealed, dry, inert-filled containers: Material ships in UN-certified lined steel drums, stainless returnable containers, or high-density polyethylene drums closed under dry nitrogen with gasketed fittings and tamper-evident seals, filled at low humidity and labelled with fill and retest dates. Because water is the critical impurity for battery grade, moisture-barrier closures and, for high-value lots, inner sealed liners are standard practice.
• Temperature control and dedicated equipment: Storage and transit should be cool, commonly refrigerated or temperature-controlled where the supplier's stability data supports it, and containers must be kept away from heat sources and from basic or nucleophilic materials. Dedicated or passivated equipment prevents metallic and alkaline contamination, and sampling must be done in contained systems.

6.2 Dangerous Goods Identification and Transit Protocols

Transport classification follows the notified hazard statement and must be read from Section 14 of the current safety data sheet for the specific grade: where acute toxicity is notified, consignments can fall under UN 2810 toxic liquid, organic, n.o.s. as Class 6.1, whereas a formulation notified only for irritation moves as general cargo. Because this determination changes packaging, labelling, segregation, and emergency response, it must be confirmed in writing before booking. Shipments under IMDG, ADR, or IATA require compatible inner packaging, exclusion of nucleophilic co-loaded cargo, cool stowage, and documented procedures with a validated quench and spill kit.

VII. Enterprise Global Expansion Strategy Guide

Expansion in this market is won through qualification depth rather than price. Cell makers and pharmaceutical customers qualify slowly, audit thoroughly, and change suppliers reluctantly, so the winning strategy is to remove every reason for a customer's compliance function to object. The following three moves consistently achieve that.

1. Build the containment and toxicology dossier first: Invest in closed-system manufacture, an occupational exposure band with a documented health-based exposure limit, worker training and health surveillance, and a validated waste quench, then present the evidence proactively. Customers buying an alkylating sultone audit these controls before they discuss price, and a documented dossier shortens qualification by months.
2. Separate battery and pharmaceutical specification architectures: Publish battery-grade limits for water, free acid, chloride, and trace metals with ICP-MS and ion chromatography data, and a separate pharmaceutical specification covering residual sultone, genotoxic impurity assessment under ICH M7, and solvent and metal declarations. Serving both from one undifferentiated certificate satisfies neither customer.
3. Plan for substitution and qualify adjacent chemistries: Customers are actively comparing 1,3-propane sultone, unsaturated sultones, sulfate ester film formers, and fluorinated carbonate additives on the balance of performance and hazard. Suppliers who can offer an alternative and document the trade-off retain the account even if the molecule changes; suppliers who defend a single product lose it.

VIII. Conclusion

1,4-Butane sultone is a technically elegant molecule with a demanding compliance profile. Its commercial value rests on clean sulfobutylation and on interfacial film formation in lithium-ion electrolytes, and its commercial risk rests on the fact that the same electrophilicity that makes it useful makes it a potent alkylating agent. Buyers who verify the current classification, handle the material under an occupational exposure band with closed systems and health surveillance, control water and chloride for battery use, and manage residual sultone as a potential mutagenic impurity under ICH M7 will be able to use it safely and auditable.

Into 2026 and beyond, three trends will shape the market. Battery volume growth pulls demand upward; European and Japanese customers push toward the least hazardous effective molecule, favouring butane sultone over the more strained and more severely classified propane sultone while also qualifying sulfate ester and fluorinated carbonate alternatives; and carbon footprint, due diligence, and digital battery passport requirements cascade regulatory data requests down to additive suppliers. Participants who pair containment-grade operations with specification architecture and carbon data will hold these accounts.

IX. Industry Resource Connection and Supplier Ecosystem

Powered by Guidechem

This white paper is exclusively compiled by the Guidechem Intelligence Team based on global customs data, regulatory databases, and industry research. Guidechem is a leading global B2B chemical platform, dedicated to connecting global buyers with verified, high-quality manufacturers.

Guidechem Global 1,4-Butane sultone (BS) Supplier Ecosystem List

Relying on Guidechem's extensive global database, we have mapped the core participants in the current global 1,4-Butane sultone (BS) supply chain:

• China — Jiangsu, Shandong and Zhejiang electrolyte additive base: The largest concentration of sultone and electrolyte additive capacity, co-located with electrolyte blending and cell manufacturing, supplying battery grade at scale and increasingly investing in the closed-system finishing and trace-metal control needed for export qualification.
• Japan and Korea — electronic-grade specialists serving cell makers: Producers integrated with domestic battery materials industries supply very low water, acid, and chloride grades with full trace-metal certification and batch genealogy, and set the specification benchmark that battery customers apply worldwide.
• European Union — Germany, Switzerland and Italy containment-grade custom synthesis: High-containment CDMOs and speciality manufacturers serve pharmaceutical sulfobutylation and speciality intermediate customers with occupational exposure banding, ICH M7 documentation, REACH dossiers, and validated quench and destruction procedures.